Tags

Type your tag names separated by a space and hit enter

Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Hum Reprod. 2005 Apr; 20(4):915-22.HR

Abstract

BACKGROUND

Anti-Müllerian hormone (AMH) has been recently proposed as a marker for ovarian ageing and poor ovarian response to controlled ovarian hyperstimulation in assisted reproduction cycles. The present study was undertaken to investigate the usefulness of baseline cycle day 3 AMH levels and AMH serum concentrations obtained on the fifth day of gonadotropin therapy in predicting ovarian response and pregnancy in women undergoing ovarian stimulation with FSH under pituitary desensitization for assisted reproduction.

METHODS

A total of 80 women undergoing their first cycle of IVF/intracytoplasmic sperm injection (ICSI) treatment were studied. Twenty consecutive cycles which were cancelled because of a poor follicular response were initially selected. As a control group, 60 women were randomly selected from our assisted reproduction programme matching by race, age, body mass index, basal FSH and indication for IVF/ICSI to those in the cancelled group. For each cancelled patient, three IVF/ICSI women who met the matching criteria were included.

RESULTS

Basal and day 5 AMH serum concentrations were significantly lower in the cancelled than in the control group. Receiver-operating characteristic (ROC) analysis showed that the capacity of day 5 AMH in predicting the likelihood of cancellation in an assisted reproduction treatment programme was significantly higher than that for basal AMH measurement. However, the predictive capacity of day 5 AMH was not better than that provided by day 5 estradiol. In addition, neither basal nor day 5 AMH or estradiol measurements were useful in the prediction of pregnancy after assisted reproductive treatment.

CONCLUSIONS

AMH concentrations obtained early in the follicular phase during ovarian stimulation under pituitary suppression for assisted reproduction are better predictors of ovarian response than basal AMH measurements. However, AMH is not useful in the prediction of pregnancy. Definite clinical applicability of AMH determination as a marker of IVF outcome remains to be established.

Authors+Show Affiliations

Institut Clínic of Gynecology, Obstetrics and Neonatology, Faculty of Medicine-University of Barcelona, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15665015

Citation

Peñarrubia, Joana, et al. "Basal and Stimulation Day 5 anti-Mullerian Hormone Serum Concentrations as Predictors of Ovarian Response and Pregnancy in Assisted Reproductive Technology Cycles Stimulated With Gonadotropin-releasing Hormone Agonist--gonadotropin Treatment." Human Reproduction (Oxford, England), vol. 20, no. 4, 2005, pp. 915-22.
Peñarrubia J, Fábregues F, Manau D, et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Hum Reprod. 2005;20(4):915-22.
Peñarrubia, J., Fábregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., Carmona, F., Vanrell, J. A., & Balasch, J. (2005). Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Human Reproduction (Oxford, England), 20(4), 915-22.
Peñarrubia J, et al. Basal and Stimulation Day 5 anti-Mullerian Hormone Serum Concentrations as Predictors of Ovarian Response and Pregnancy in Assisted Reproductive Technology Cycles Stimulated With Gonadotropin-releasing Hormone Agonist--gonadotropin Treatment. Hum Reprod. 2005;20(4):915-22. PubMed PMID: 15665015.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. AU - Peñarrubia,Joana, AU - Fábregues,Francisco, AU - Manau,Dolors, AU - Creus,Montserrat, AU - Casals,Gemma, AU - Casamitjana,Roser, AU - Carmona,Franciso, AU - Vanrell,Juan A, AU - Balasch,Juan, Y1 - 2005/01/21/ PY - 2005/1/25/pubmed PY - 2005/7/1/medline PY - 2005/1/25/entrez SP - 915 EP - 22 JF - Human reproduction (Oxford, England) JO - Hum Reprod VL - 20 IS - 4 N2 - BACKGROUND: Anti-Müllerian hormone (AMH) has been recently proposed as a marker for ovarian ageing and poor ovarian response to controlled ovarian hyperstimulation in assisted reproduction cycles. The present study was undertaken to investigate the usefulness of baseline cycle day 3 AMH levels and AMH serum concentrations obtained on the fifth day of gonadotropin therapy in predicting ovarian response and pregnancy in women undergoing ovarian stimulation with FSH under pituitary desensitization for assisted reproduction. METHODS: A total of 80 women undergoing their first cycle of IVF/intracytoplasmic sperm injection (ICSI) treatment were studied. Twenty consecutive cycles which were cancelled because of a poor follicular response were initially selected. As a control group, 60 women were randomly selected from our assisted reproduction programme matching by race, age, body mass index, basal FSH and indication for IVF/ICSI to those in the cancelled group. For each cancelled patient, three IVF/ICSI women who met the matching criteria were included. RESULTS: Basal and day 5 AMH serum concentrations were significantly lower in the cancelled than in the control group. Receiver-operating characteristic (ROC) analysis showed that the capacity of day 5 AMH in predicting the likelihood of cancellation in an assisted reproduction treatment programme was significantly higher than that for basal AMH measurement. However, the predictive capacity of day 5 AMH was not better than that provided by day 5 estradiol. In addition, neither basal nor day 5 AMH or estradiol measurements were useful in the prediction of pregnancy after assisted reproductive treatment. CONCLUSIONS: AMH concentrations obtained early in the follicular phase during ovarian stimulation under pituitary suppression for assisted reproduction are better predictors of ovarian response than basal AMH measurements. However, AMH is not useful in the prediction of pregnancy. Definite clinical applicability of AMH determination as a marker of IVF outcome remains to be established. SN - 0268-1161 UR - https://www.unboundmedicine.com/medline/citation/15665015/Basal_and_stimulation_day_5_anti_Mullerian_hormone_serum_concentrations_as_predictors_of_ovarian_response_and_pregnancy_in_assisted_reproductive_technology_cycles_stimulated_with_gonadotropin_releasing_hormone_agonist__gonadotropin_treatment_ L2 - https://academic.oup.com/humrep/article-lookup/doi/10.1093/humrep/deh718 DB - PRIME DP - Unbound Medicine ER -